** Shares of Cipla CIPL.NS down 2.5% at 1541 rupees
** Indian drugmaker says its global CEO and MD, Umang Vohra, will step down, effective March 26
** Achin Gupta, co's global COO, to take over the role
** Stock on track to snap four straight weeks of gains
** More than 2.8 mln shares traded, 2x their 30-day moving avg
** Avg rating of 35 analysts is "buy" and median PT is 1,727.50 rupees, ~12% higher than current price - data compiled by LSEG
** YTD, however, CIPL nearly flat
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))